The diverse functions of Dot1 and H3K79 methylationanh

Genes and Development

Volumn 25, Issue 13, 2011, Pages 1345-1358

  Nguyen, Anh Tram ^a   Zhang, Yi ^b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Chromatin; DOT1; Epigenetics; Histone; Leukemia; Transcription

Indexed keywords

DISRUPTOR OF TELOMERIC SILENCING; DODECYL SULFATE SODIUM; DYSTROPHIN ASSOCIATED PROTEIN; H3K79; HISTONE H2B; HISTONE H3; METHYLTRANSFERASE; PROTEIN; PROTEIN ARGININE METHYLTRANSFERASE; SILENT INFORMATION REGULATOR PROTEIN; TRANSCRIPTION ELONGATION FACTOR; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR HOXA9; UNCLASSIFIED DRUG;

BIOLOGICAL ACTIVITY; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CHROMATIN STRUCTURE; DEMETHYLATION; DNA DAMAGE; DNA REPAIR; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ERYTHROPOIESIS; GENOME ANALYSIS; HEART FUNCTION; HETEROCHROMATIN; HISTONE METHYLATION; HISTONE UBIQUITINATION; HUMAN; LEUKEMIA; MOLECULAR INTERACTION; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN INTERACTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REVIEW; SACCHAROMYCES CEREVISIAE; TANDEM MASS SPECTROMETRY; TRANSCRIPTION REGULATION;

ANIMALS; CELL CYCLE; DNA REPAIR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTONES; HUMANS; METHYLATION; METHYLTRANSFERASES;

MAMMALIA; MUS; SACCHAROMYCETALES;

EID: 79959960773     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.2057811     Document Type: Review

References (110)

1. Altaf M, Utley RT, Lacoste N, Tan S, Briggs SD, Cote J. 2007. Interplay of chromatin modifiers on a short basic patch of histone H4 tail defines the boundary of telomeric heterochromatin. Mol Cell 28: 1002-1014.
2. Ayton PM, Cleary ML. 2001. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20: 5695-5707.
3. Barry ER, Krueger W, Jakuba CM, Veilleux E, Ambrosi DJ, Nelson CE, Rasmussen TP. 2009. ES cell cycle progression and differentiation require the action of the histone methyltransferase Dot1L. Stem Cells 27: 1538-1547.
4. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. 2007. High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837.
5. Bitoun E, Oliver PL, Davies KE. 2007. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum Mol Genet 16: 92-106.
6. Bostelman LJ, Keller AM, Albrecht AM, Arat A, Thompson JS. 2007. Methylation of histone H3 lysine-79 by Dot1p plays multiple roles in the response to UV damage in Saccharomyces cerevisiae. DNA Repair (Amst) 6: 383-395.
7. Briggs SD, Xiao T, Sun ZW, Caldwell JA, Shabanowitz J, Hunt DF, Allis CD, Strahl BD. 2002. Gene silencing: trans-histone regulatory pathway in chromatin. Nature 418: 498.
8. Cavalli G. 2006. Chromatin and epigenetics in development: blending cellular memory with cell fate plasticity. Development 133: 2089-2094.
9. Chandrasekharan MB, Huang F, Sun ZW. 2009. Ubiquitination of histone H2B regulates chromatin dynamics by enhancing nucleosome stability. Proc Natl Acad Sci 106: 16686-16691.
10. Chang MJ, Wu H, Achille NJ, Reisenauer MR, Chou CW, Zeleznik-Le NJ, Hemenway CS, Zhang W. 2010. Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes. Cancer Res 70: 10234-10242.
11. Chatterjee C, McGinty RK, Fierz B, Muir TW. 2010. Disulfidedirected histone ubiquitylation reveals plasticity in hDot1L activation. Nat Chem Biol 6: 267-269.
12. Cheng X, Roberts RJ. 2001. AdoMet-dependent methylation, DNA methyltransferases and base flipping. Nucleic Acids Res 29: 3784-3795.
13. Chernikova SB, Dorth JA, Razorenova OV, Game JC, Brown JM. 2010. Deficiency in Bre1 impairs homologous recombination repair and cell cycle checkpoint response to radiation damage in mammalian cells. Radiat Res 174: 558-565.
14. Cloos PA, Christensen J, Agger K, Helin K. 2008. Erasing the methyl mark: histone demethylases at the center of cellulardifferentiation and disease. Genes Dev 22: 1115-1140.
15. Conde F, San-Segundo PA. 2008. Role of Dot1 in the response to alkylating DNA damage in Saccharomyces cerevisiae: regulation of DNA damage tolerance by the error-prone polymerases Polzeta/Rev1. Genetics 179: 1197-1210.
16. Conde F, Refolio E, Cordon-Preciado V, Cortes-Ledesma F, Aragon L, Aguilera A, San-Segundo PA. 2009. The Dot1 histone methyltransferase and the Rad9 checkpoint adaptor contribute to cohesin-dependent double-strand break repair by sister chromatid recombination in Saccharomyces cerevisiae.
17. Genetics 182: 437-446.
18. Conde F, Ontoso D, Acosta I, Gallego-Sanchez A, Bueno A, San- Segundo PA. 2010. Regulation of tolerance to DNA alkylating damage by Dot1 and Rad53 in Saccharomyces cerevisiae. DNA Repair (Amst) 9: 1038-1049.
19. Daser A, Rabbitts TH. 2004. Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Genes Dev 18: 965-974.
20. Ezhkova E, Tansey WP. 2004. Proteasomal ATPases link ubiquitylation of histone H2B to methylation of histone H3. Mol Cell 13: 435-442.
21. Feinberg AP, Oshimura M, Barrett JC. 2002. Epigenetic mechanisms in human disease. Cancer Res 62: 6784-6787.
22. Feng Q, Wang H, Ng HH, Erdjument-Bromage H, Tempst P, Struhl K, Zhang Y. 2002. Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain. Curr Biol 12: 1052-1058.
23. Feng Y, Yang Y, Ortega MM, Copeland JN, Zhang M, Jacob JB, Fields TA, Vivian JL, Fields PE. 2010. Early mammalian erythropoiesis requires the Dot1L methyltransferase. Blood 116: 4483-4491.
24. Fierz B, Chatterjee C, McGinty RK, Bar-Dagan M, Raleigh DP, Muir TW. 2011. Histone H2B ubiquitylation disrupts local and higher-order chromatin compaction. Nat Chem Biol 7: 113-119.
25. Fingerman IM, Li HC, Briggs SD. 2007. A charge-based interaction between histone H4 and Dot1 is required for H3K79 methylation and telomere silencing: identification of a new trans-histone pathway. Genes Dev 21: 2018-2029.
26. Frederiks F, Tzouros M, Oudgenoeg G, van Welsem T, Fornerod M, Krijgsveld J, van Leeuwen F. 2008. Nonprocessive methylation by Dot1 leads to functional redundancy of histone H3K79 methylation states. Nat Struct Mol Biol 15: 550-557.
27. Game JC, Williamson MS, Spicakova T, Brown JM. 2006. The RAD6/BRE1 histone modification pathway in Saccharomyces confers radiation resistance through a RAD51-dependent process that is independent of RAD18. Genetics 173: 1951-1968.
28. Giannattasio M, Lazzaro F, Plevani P, Muzi-Falconi M. 2005. The DNA damage checkpoint response requires histone H2B ubiquitination by Rad6-Bre1 and H3 methylation by Dot1. J Biol Chem 280: 9879-9886.
29. Grenon M, Costelloe T, Jimeno S, O'Shaughnessy A, Fitzgerald J, Zgheib O, Degerth L, Lowndes NF. 2007. Docking onto chromatin via the Saccharomyces cerevisiae Rad9 Tudor domain. Yeast 24: 105-119.
30. Guenther MG, Jenner RG, Chevalier B, Nakamura T, Croce CM, Canaani E, Young RA. 2005. Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci 102: 8603-8608.
31. Handel AE, Ebers GC, Ramagopalan SV. 2010. Epigenetics: molecular mechanisms and implications for disease. Trends Mol Med 16: 7-16.
32. Hess JL. 2004. MLL: a histone methyltransferase disrupted in leukemia. Trends Mol Med 10: 500-507.
33. Hsieh JJ, Cheng EH, Korsmeyer SJ. 2003. Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression. Cell 115: 293-303.
34. Huyen Y, Zgheib O, Ditullio RA Jr, Gorgoulis VG, Zacharatos P, Petty TJ, Sheston EA, Mellert HS, Stavridi ES, Halazonetis TD. 2004. Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature 432: 406-411.
35. Illi B, Scopece A, Nanni S, Farsetti A, Morgante L, Biglioli P, Capogrossi MC, Gaetano C. 2005. Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. Circ Res 96: 501-508.
36. Im H, Park C, Feng Q, Johnson KD, Kiekhaefer CM, Choi K, Zhang Y, Bresnick EH. 2003. Dynamic regulation of histone H3 methylated at lysine 79 within a tissue-specific chromatin domain. J Biol Chem 278: 18346-18352.
37. Javaheri A, Wysocki R, Jobin-Robitaille O, Altaf M, Cote J, Kron SJ. 2006. Yeast G1 DNA damage checkpoint regulation by H2A phosphorylation is independent of chromatin remodeling. Proc Natl Acad Sci 103: 13771-13776.
38. Jenuwein T, Laible G, Dorn R, Reuter G. 1998. SET domain proteins modulate chromatin domains in eu- and heterochromatin. Cell Mol Life Sci 54: 80-93.
39. Jo SY, Granowicz EM, Maillard I, Thomas D, Hess JL. 2011. Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation. Blood 117: 4758-4759.
40. Jones B, Su H, Bhat A, Lei H, Bajko J, Hevi S, Baltus GA, Kadam S, Zhai H, Valdez R, et al. 2008. The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure. PLoS Genet 4: e1000190. doi: 10.1371/journal.pgen.1000190.
41. Katan-Khaykovich Y, Struhl K. 2005. Heterochromatin formation involves changes in histone modifications over multiple cell generations. EMBO J 24: 2138-2149.
42. Kimura A. 2008. Molecular etiology and pathogenesis of hereditary cardiomyopathy. Circ J 72: A38-A48. doi: 10.1253/ circj.CJ-08-0050.
43. Klose RJ, Zhang Y. 2007. Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol 8: 307-318.
44. Klose RJ, Kallin EM, Zhang Y. 2006. JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet 7: 715-727.
45. Kornberg RD, Lorch Y. 1999. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98: 285-294.
46. Kouskouti A, Talianidis I. 2005. Histone modifications defining active genes persist after transcriptional and mitotic inactivation. EMBO J 24: 347-357.
47. Kouzarides T. 2002. Histone methylation in transcriptional control. Curr Opin Genet Dev 12: 198-209.
48. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128: 693-705.
49. Krivtsov AV, Armstrong SA. 2007. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 7: 823-833.
50. Krivtsov AV, Feng Z, Lemieux ME, Faber J, Vempati S, Sinha AU, Xia X, Jesneck J, Bracken AP, Silverman LB, et al. 2008.H3K79 methylation profiles define murine and human MLLAF4 leukemias. Cancer Cell 14: 355-368.
51. Krogan NJ, Dover J, Wood A, Schneider J, Heidt J, Boateng MA, Dean K, Ryan OW, Golshani A, Johnston M, et al. 2003. The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation. Mol Cell 11: 721-729.
52. Lacoste N, Utley RT, Hunter JM, Poirier GG, Cote J. 2002. Disruptor of telomeric silencing-1 is a chromatin-specific histone H3 methyltransferase. J BiolChem 277: 30421-30424.
53. Laurenson P, Rine J. 1992. Silencers, silencing, and heritable transcriptional states. Microbiol Rev 56: 543-560.
54. Lazzaro F, Sapountzi V, Granata M, Pellicioli A, Vaze M, Haber JE, Plevani P, Lydall D, Muzi-Falconi M. 2008. Histone methyltransferase Dot1 and Rad9 inhibit single-stranded DNA accumulation at DSBs and uncapped telomeres. EMBO J 27: 1502-1512.
55. Lee JS, Shukla A, Schneider J, Swanson SK, Washburn MP, Florens L, Bhaumik SR, Shilatifard A. 2007. Histone crosstalk between H2B monoubiquitination and H3 methylation mediated by COMPASS. Cell 131: 1084-1096.
56. Levesque N, Leung GP, Fok AK, Schmidt TI, Kobor MS. 2010. Loss of H3 K79 trimethylation leads to suppression of Rtt107-dependent DNA damage sensitivity through the translesion synthesis pathway. J Biol Chem 285: 35113-35122.
57. Lin C, Smith ER, Takahashi H, Lai KC, Martin-Brown S, Florens L, Washburn MP, Conaway JW, Conaway RC, Shilatifard A. 2010. AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia. Mol Cell 37: 429-437.
58. Liu W, Tanasa B, Tyurina OV, Zhou TY, Gassmann R, Liu WT, Ohgi KA, Benner C, Garcia-Bassets I, Aggarwal AK, et al. PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression. Nature 466: 508-512
59. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. 1997. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389: 251-260.
60. Martin C, Zhang Y. 2005. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 6: 838-849.
61. McGinty RK, Kim J, Chatterjee C, Roeder RG, Muir TW. 2008. Chemically ubiquitylated histone H2B stimulates hDot1Lmediated intranucleosomal methylation. Nature 453: 812-816.
62. Min J, Feng Q, Li Z, Zhang Y, Xu RM. 2003. Structure of the atalytic domain of human DOT1L, a non-SET domain nucleosomal histone methyltransferase. Cell 112: 711-723.
63. Minard ME, Jain AK, Barton MC. 2009. Analysis of epigenetic alterations to chromatin during development. Genesis 47: 559-572.
64. Mohan M, Herz HM, Takahashi YH, Lin C, Lai KC, Zhang Y, Washburn MP, Florens L, Shilatifard A. 2010. Linking H3K79 trimethylation to Wnt signaling through a novel Dot1- containing complex (DotCom). Genes Dev 24: 574-589.
65. Mueller D, Bach C, Zeisig D, Garcia-Cuellar MP, Monroe S, Sreekumar A, Zhou R, Nesvizhskii A, Chinnaiyan A, Hess JL, et al. 2007. A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. Blood 110: 4445-4454.
66. Mueller D, Garcia-Cuellar MP, Bach C, Buhl S, Maethner E, Slany RK. 2009. Misguided transcriptional elongation causes mixed lineage leukemia. PLoS Biol 7: e1000249. doi: 10.1371/jounral.pbio.1000249.
67. Ng HH, Feng Q, Wang H, Erdjument-Bromage H, Tempst P, Zhang Y, Struhl K. 2002a. Lysine methylation within the globular domain of histone H3 by Dot1 is important for telomeric silencing and Sir protein association. Genes Dev 16: 1518-1527.
68. Ng HH, Xu RM, Zhang Y, Struhl K. 2002b. Ubiquitination of histone H2B by Rad6 is required for efficient Dot1-mediated methylation of histone H3 lysine 79. J Biol Chem 277: 34655-34657.
69. Ng HH, Ciccone DN, Morshead KB, Oettinger MA, Struhl K. 2003a. Lysine-79 of histone H3 is hypomethylated at silenced loci in yeast and mammalian cells: a potential mechanism for position-effect variegation. Proc Natl Acad Sci 100: 1820-1825.
70. Ng HH, Dole S, Struhl K. 2003b. The Rtf1 component of the Paf1 transcriptional elongation complex is required for ubiquitination of histone H2B. J Biol Chem 278: 33625-33628.
71. Nguyen AT, Taranova O, He J, Zhang Y. 2011a. DOT1L, the H3K79 methyltransferase, is required for MLL-AF9 leukemogenesis. Blood. doi: 10.1182/blood-2011-02-334369.
72. Nguyen AT, Xiao B, Neppl RL, Kallin EM, Li J, Chen T, Wang DZ, Xiao X, Zhang Y. 2011b. DOT1L regulates dystrophin expression and is critical for cardiac function. Genes Dev 25: 263-274.
73. Norris A, Boeke JD. 2010. Silent information regulator 3: the Goldilocks of the silencing complex. Genes Dev 24: 115-122.
74. Oh S, Jeong K, Kim H, Kwon CS, Lee D. 2010. A lysine-rich region in Dot1p is crucial for direct interaction with H2B ubiquitylation and high level methylation of H3K79. Biochem
75. Oh S, Jeong K, Kim H, Kwon CS, Lee D. 2010. A lysine-rich region in Dot1p is crucial for direct interaction with H2B ubiquitylation and high level methylation of H3K79. Biochem Biophys Res Commun 399: 512-517
76. Okada Y, Feng Q, Lin Y, Jiang Q, Li Y, Coffield VM, Su L, Xu G, Zhang Y. 2005. hDOT1L links histone methylation to leukemogenesis. Cell 121: 167-178.
77. Okada Y, Jiang Q, Lemieux M, Jeannotte L, Su L, Zhang Y. 2006. Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L. Nat Cell Biol 8: 1017-1024.
78. Onishi M, Liou GG, Buchberger JR, Walz T, Moazed D. 2007. Role of the conserved Sir3-BAH domain in nucleosome binding and silent chromatin assembly. Mol Cell 28: 1015-1028.
79. Ooga M, Inoue A, Kageyama S, Akiyama T, Nagata M, Aoki F. 2008. Changes in H3K79 methylation during preimplantation development in mice. Biol Reprod 78: 413-424.
80. Peterson CL, Laniel MA. 2004. Histones and histone modifications. Curr Biol 14: R546-R551. doi: 10.1016/j.cub.2004.07.007.
81. Pokholok DK, Harbison CT, Levine S, Cole M, Hannett NM, Lee TI, Bell GW, Walker K, Rolfe PA, Herbolsheimer E, et al. 2005. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 122: 517-527.
82. Qi HH, Sarkissian M, Hu GQ, Wang Z, Bhattacharjee A, Gordon DB, Gonzales M, Lan F, Ongusaha PP, Huarte M, et al. 2010. Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development. Nature 466: 503-507.
83. Ringrose L, Paro R. 2004. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu Rev Genet 38: 413-443.
84. Robzyk K, Recht J, Osley MA. 2000. Rad6-dependent ubiquitination of histone H2B in yeast. Science 287: 501-504.
85. Rossmann MP, Luo W, Tsaponina O, Chabes A, Stillman B. 2011. A common telomeric gene silencing assay is affected by nucleotide metabolism. Mol Cell 42: 127-136.
86. San-Segundo PA, Roeder GS. 2000. Role for the silencing protein Dot1 in meiotic checkpoint control. Mol Biol Cell 11: 3601-3615.
87. Sawada K, Yang Z, Horton JR, Collins RE, Zhang X, Cheng X. 2004. Structure of the conserved core of the yeast Dot1p, a nucleosomal histone H3 lysine 79 methyltransferase. J Biol Chem 279: 43296-43306.
88. Schubeler D, MacAlpine DM, Scalzo D, Wirbelauer C, Kooperberg C, van Leeuwen F, Gottschling DE, O'Neill LP, Turner BM, Delrow J, et al. 2004. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev 18: 1263-1271.
89. Schubert HL, Blumenthal RM, Cheng X. 2003. Many paths to methyltransfer: a chronicle of convergence. Trends Biochem Sci 28: 329-335.
90. Schulze JM, Jackson J, Nakanishi S, Gardner JM, Hentrich T, Haug J, Johnston M, Jaspersen SL, Kobor MS, Shilatifard A. 2009. Linking cell cycle to histone modifications: SBF and H2B monoubiquitination machinery and cell-cycle regulation of H3K79 dimethylation. Mol Cell 35: 626-641.
91. Shanower GA, Muller M, Blanton JL, Honti V, Gyurkovics H, Schedl P. 2005. Characterization of the grappa gene, the Drosophila histone H3 lysine 79 methyltransferase. Genetics 169: 173-184.
92. Singer MS, Kahana A, Wolf AJ, Meisinger LL, Peterson SE, Goggin C, Mahowald M, Gottschling DE. 1998. Identification of high-copy disruptors of telomeric silencing in Saccharomyces cerevisiae. Genetics 150: 613-632.
93. Steger DJ, Lefterova MI, Ying L, Stonestrom AJ, Schupp M, Zhuo D, Vakoc AL, Kim JE, Chen J, Lazar MA, et al. 2008. DOT1L/ KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol Cell Biol 28: 2825-2839.
94. Strahl BD, Allis CD. 2000. The language of covalent histone modifications. Nature 403: 41-45.
95. Sun ZW, Allis CD. 2002. Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast. Nature 418: 104-108.
96. Takahashi YH, Schulze JM, Jackson J, Hentrich T, Seidel C, Jaspersen SL, Kobor MS, Shilatifard A. 2011. Dot1 and histone H3K79 methylation in natural telomeric and HM silencing. Mol Cell 42: 118-126.
97. Toh GW, O'Shaughnessy AM, Jimeno S, Dobbie IM, Grenon M, Maffini S, O'Rorke A, Lowndes NF. 2006. Histone H2A phosphorylation and H3 methylation are required for a novel Rad9 DSB repair function following checkpoint activation. DNA Repair (Amst) 5: 693-703.
98. Vakoc CR, Sachdeva MM, Wang H, Blobel GA. 2006. Profile of histone lysine methylation across transcribed mammalian chromatin. Mol Cell Biol 26: 9185-9195.
99. Van Holde KE, Allen JR, Tatchell K, Weischet WO, Lohr D. 1980. DNA-histone interactions in nucleosomes. Biophys J 32: 271-282.
100. van Leeuwen F, Gafken PR, Gottschling DE. 2002. Dot1p modulates silencing in yeast by methylation of the nucleosome core. Cell 109: 745-756.
101. van Welsem T, Frederiks F, Verzijlbergen KF, Faber AW, Nelson ZW, Egan DA, Gottschling DE, van Leeuwen F. 2008. Synthetic lethal screens identify gene silencing processes in yeast and implicate the acetylated amino terminus of Sir3 in recognition of the nucleosome core. Mol Cell Biol 28: 3861-3872.
102. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, Cui K, Roh TY, Peng W, Zhang MQ, et al. 2008. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40: 897-903.
103. Wood A, Krogan NJ, Dover J, Schneider J, Heidt J, Boateng MA, Dean K, Golshani A, Zhang Y, Greenblatt JF, et al. 2003a. Bre1, an E3 ubiquitin ligase required for recruitment and substrate selection of Rad6 at a promoter. Mol Cell 11: 267-274.
104. Wood A, Schneider J, Dover J, Johnston M, Shilatifard A. 2003b. The Paf1 complex is essential for histone monoubiquitination by the Rad6-Bre1 complex, which signals for histone methylation by COMPASS and Dot1p. J Biol Chem 278: 34739-34742.
105. Wysocki R, Javaheri A, Allard S, Sha F, Cote J, Kron SJ. 2005. Role of Dot1-dependent histone H3 methylation in G1 and S phase DNA damage checkpoint functions of Rad9. Mol Cell Biol 25: 8430-8443.
106. Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, Ito S, Yang C, Xiao MT, Liu LX, et al. 2011. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of a-ketoglutarate-dependent dioxygenases. Cancer Cell 19: 17-30.
107. Yokoyama A, Lin M, Naresh A, Kitabayashi I, Cleary ML. 2010. A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription. Cancer Cell 17: 198-212.
108. Zhang K, Dent SY. 2005. Histone modifying enzymes and cancer: going beyond histones. J Cell Biochem 96: 1137-1148.
109. Zhang Y, Reinberg D. 2001. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev 15: 2343-2360.
110. Zhang W, Hayashizaki Y, Kone BC. 2004. Structure and regulation of the mDot1 gene, a mouse histone H3 methyltransferase. Biochem J 377: 641-651.